Bristol-Myers Gains After Starboard Takes a Position

(Bloomberg) -- Shares of drugmaker Bristol-Myers Squibb Co. gained Monday, with acquisition target Celgene Corp. falling after activist hedge fund Starboard Value was said to have taken a stake in ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.